Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genomics02:02

Genomics

39.6K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
39.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting Synaptic Vesicle Endocytosis in Nociceptors Provides Sustained Pain Relief.

bioRxiv : the preprint server for biology·2026
Same author

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Clinical and pathological predictors of early recurrence after neoadjuvant cisplatin gemcitabine in muscle invasive bladder cancer in the RealBLADDER study.

Scientific reports·2026
Same author

A mixed prebiotic/probiotic intervention (MBR-01) for the management of diarrhea during abemaciclib treatment of early breast cancer in postmenopausal patients: A single-center prospective case-control pilot study.

Breast (Edinburgh, Scotland)·2026
Same author

Preclinical models of female pelvic pain disorders.

Pain·2026
Same author

Menstrual distress in medical students: symptomatic burden, attitudes, and perceived unmet educational needs.

The journal of sexual medicine·2026

Related Experiment Video

Updated: Jan 13, 2026

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

2.0K

Navigating Cancer Complexity: Integrative Multi-Omics Methodologies for Clinical Insights.

Martina Catalano1, Alberto D'Angelo2, Francesco De Logu1

  • 1Department of Health Sciences, Section of Clinical Pharmacology Oncology, University of Florence, Florence, Italy.

Clinical Medicine Insights. Oncology
|October 28, 2025
PubMed
Summary

Cancer multi-omics integrates diverse data to reveal biomarkers and targets. This approach enhances personalized therapies and improves patient outcomes by deepening our understanding of cancer biology.

Keywords:
Cancer multi-omicsbiomarkersintegrative network modelspersonalized therapiesproteogenomictherapeutic targets

More Related Videos

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.1K
Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry
06:51

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry

Published on: November 14, 2025

267

Related Experiment Videos

Last Updated: Jan 13, 2026

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

2.0K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.1K
Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry
06:51

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry

Published on: November 14, 2025

267

Area of Science:

  • Oncology
  • Bioinformatics
  • Molecular Biology

Background:

  • Cancer multi-omics integrates genomics, transcriptomics, proteomics, and metabolomics.
  • These approaches provide deeper insights into the molecular intricacies of various cancers.
  • Challenges include integrating disparate data types and interpreting complex interactions.

Purpose of the Study:

  • To review advancements in cancer multi-omics.
  • To highlight the identification of novel biomarkers and therapeutic targets.
  • To discuss the potential of multi-omics in cancer drug discovery and personalized therapies.

Main Methods:

  • Integrative analysis of multi-omics data (genomics, transcriptomics, proteomics, metabolomics).
  • Application of proteogenomics and mass spectrometry.
  • Development of integrative network-based models.

Main Results:

  • Identification of novel biomarkers and therapeutic targets across various cancers.
  • Enhanced correlation between molecular profiles and clinical features.
  • Refined prediction of therapeutic responses.

Conclusions:

  • Multi-omics approaches are transforming cancer research and drug discovery.
  • Addressing challenges in data integration and interpretation is crucial.
  • Standardized frameworks can optimize target identification and advance personalized medicine for improved patient outcomes.